Search
for
Sort by
Research 61–90 of 1000+
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- 220 Dynamic and spatial transcriptional responses in COVID-19-related chilblains
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- New drugs under investigation for the treatment of alopecias
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia